Germany’s neighbours eye share of Merz’s big spending plans

Neil Hopper, a 49-year-old vascular surgeon from Cornwall who performed hundreds of amputations, has been charged with fraud and encouraging grievous bodily harm after lying to insurers about his leg injuries and purchasing videos related to illegal limb removals. Suspended from his position since March 2023, there is no evidence suggesting risk to patients from his professional conduct. Want More Context? 🔎

On a July morning, Dan and Theresa Mosier reflect on their friendship with Don Cherry, who would retreat to Wolfe Island each summer, seeking privacy from his fame as a longtime hockey commentator. After the loss of his daughter and brother, Cherry recently signed off his podcast, leading to speculation about his future, despite assurances from his son that his retirement may be exaggerated. Want More Context? 🔎

UN Secretary-General Antonio Guterres described the humanitarian crisis in Gaza as a "horror show," highlighting mass devastation, soaring malnourishment, and intensive Israeli military operations leading to further displacement. He condemned attacks on UN facilities, urged adherence to international law, and called for Security Council reform to enhance cooperation and peace efforts amid global conflicts. Want More Context? 🔎

Oregon authorities identified Amanda Lloyd, 40, and Lindsay Bashan, 33, as the victims of a fatal waterfall accident at Dillon Falls, where three people were swept over the falls; search operations are ongoing for the remaining missing individual. The incident occurred while six people floated on inner tubes, with only three survivors, and authorities have urged the public to avoid the area to facilitate recovery efforts. Want More Context? 🔎

Reem Alsalem, the United Nations Special Rapporteur on violence against women and girls, emphasizes that Palestinian women and girls are intentionally targeted by the Israeli army due to their vital role in ensuring the continuity of Palestinian life. Want More Context? 🔎

Androfeme, a testosterone cream developed in WA, offers a groundbreaking treatment for hypo-active sexual desire dysfunction, a common menopause side effect, but is not covered by the Pharmaceutical Benefits Scheme, costing $100 for a 100-day supply compared to $31.60 for men’s equivalents. Doctors advocate for its inclusion in the PBS to improve accessibility, as ongoing trials explore its effectiveness on additional menopause symptoms. Want More Context? 🔎